• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Pathnostics Study Funneling Money to Doctors?





Yes! From a friend who works for them:

Pathnostics is offering money to docs in exchange for testing so that they can increase utilization in order to gain approval of their own ICD-10 code. They are billing $1200 per test and paying docs $50 per test. This friend is looking for a new job. He plans to leave before the whole thing blows up. The Dept. of Justice is investigating.
 




Yes! From a friend who works for them:

Pathnostics is offering money to docs in exchange for testing so that they can increase utilization in order to gain approval of their own ICD-10 code. They are billing $1200 per test and paying docs $50 per test. This friend is looking for a new job. He plans to leave before the whole thing blows up. The Dept. of Justice is investigating.